Schuette W - Search Results

1

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study.

Schuette W, Schirmacher P, Eberhardt WEE, Dietel M, Zirrgiebel U, Muehlenhoff L, Thomas M. Schuette W, et al. BMC Cancer. 2018 Feb 5;18(1):135. doi: 10.1186/s12885-018-4032-3. BMC Cancer. 2018. PMID: 29402243 Free PMC article. Clinical Trial.

2

EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany: an observational study.

Schuette W, Schirmacher P, Eberhardt WE, Fischer JR, von der Schulenburg JM, Mezger J, Schumann C, Serke M, Zaun S, Dietel M, Thomas M. Schuette W, et al. Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1254-61. doi: 10.1158/1055-9965.EPI-14-1149. Epub 2015 Jun 12. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26070531

3

[Subgroup Analysis of the Non-interventional REASON Study: PFS and OS According to Age, Smoking History, Gender, and Histology in NSCLC Patients Treated with Gefitinib or Chemotherapy].

Schuette W, Eberhardt WE, Waller C, Schirmacher P, Dietel M, Zirrgiebel U, Radke S, Thomas M. Schuette W, et al. Pneumologie. 2016 Sep;70(9):579-88. doi: 10.1055/s-0042-109760. Epub 2016 Sep 7. Pneumologie. 2016. PMID: 27603946 Free article. Clinical Trial. German.

4

[Exon-dependent Subgroup-analysis of the Non-interventional REASON-Study: PFS and OS in EGFR-mutated NSCLC Patients Treated with Gefitinib or Chemotherapy].

Schuette W, Dietel M, Thomas M, Eberhardt W, Griesinger F, Zirrgiebel U, Radke S, Schirmacher P. Schuette W, et al. Pneumologie. 2016 Aug;70(8):514-21. doi: 10.1055/s-0042-109749. Epub 2016 Aug 11. Pneumologie. 2016. PMID: 27512931 Free article. Clinical Trial. German.

5

Second-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of life.

Schuette W, Tesch H, Büttner H, Krause T, Soldatenkova V, Stoffregen C. Schuette W, et al. BMC Cancer. 2012 Jan 13;12:14. doi: 10.1186/1471-2407-12-14. BMC Cancer. 2012. PMID: 22244076 Free PMC article. Clinical Trial.

6

Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.

Brueckl WM, Achenbach HJ, Ficker JH, Schuette W. Brueckl WM, et al. Among authors: schuette w. BMC Cancer. 2018 Mar 27;18(1):333. doi: 10.1186/s12885-018-4208-x. BMC Cancer. 2018. PMID: 29587656 Free PMC article.

7

Multicenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatin.

Schuette W, Blankenburg T, Guschall W, Dittrich I, Schroeder M, Schweisfurth H, Chemaissani A, Schumann C, Dickgreber N, Appel T, Ukena D. Schuette W, et al. Clin Lung Cancer. 2006 Mar;7(5):338-43. doi: 10.3816/clc.2006.n.016. Clin Lung Cancer. 2006. PMID: 16640806 Clinical Trial.

8

Randomized, multicenter, open-label phase II study of gemcitabine plus single-dose versus split-dose carboplatin in the treatment of patients with advanced-stage non-small-cell lung cancer.

Schuette W, Blankenburg T, Schneider CP, von Weikersthal LF, Guetz S, Laier-Groeneveld G, Virchow JC, Chemaissani A, Reck M. Schuette W, et al. Clin Lung Cancer. 2006 Sep;8(2):135-9. doi: 10.3816/clc.2006.n.042. Clin Lung Cancer. 2006. PMID: 17026815 Clinical Trial.

9

A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer.

Schuette WH, Gröschel A, Sebastian M, Andreas S, Müller T, Schneller F, Guetz S, Eschbach C, Bohnet S, Leschinger MI, Reck M. Schuette WH, et al. Clin Lung Cancer. 2013 May;14(3):215-23. doi: 10.1016/j.cllc.2012.10.001. Epub 2013 Jan 16. Clin Lung Cancer. 2013. PMID: 23332288 Clinical Trial.

10

Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancer.

Schuette W, Nagel S, Juergens S, Bork I, Wollschlaeger B, Schaedlich S, Blankenburg T. Schuette W, et al. Clin Lung Cancer. 2005 Sep;7(2):133-7. doi: 10.3816/CLC.2005.n.029. Clin Lung Cancer. 2005. PMID: 16179101 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters